BusinessNext-Generation Live Biotherapeutics: Engineered Microbiome Consortia Target Metabolic Syndrome
Next-generation Live Biotherapeutic Products (LBPs) and engineered microbes are revolutionizing the treatment of metabol...
Read More →Business
BusinessBrain-Computer Interfaces: Endovascular Stentrodes Restore Communication in ALS Patients
Endovascular Brain-Computer Interfaces (BCIs), such as the Synchron Stentrode, are restoring communication and digital c...
Read More →
BusinessSenolytics in Clinical Trials: Clearing Senescent Cells to Reverse Frailty and Idiopathic Pulmonary Fibrosis
Senolytics, drugs designed to clear senescent "zombie" cells, are showing promising results in clinical trials for age-r...
Read More →
BusinessUniversal Influenza Vaccine: mRNA and Nanoparticle Platforms Target Conserved Stalk for Broad Protection
Medical researchers are developing a universal influenza vaccine using mRNA and nanoparticle platforms to target the con...
Read More →
BusinessAI-Discovered Antibiotics: Machine Learning Identifies Novel Molecular Scaffolds Against ESKAPE Pathogens
Artificial intelligence is revitalizing antibiotic discovery by identifying novel molecular scaffolds and designing new ...
Read More →
BusinessXenotransplantation Milestones: 10-Gene Edited Pig Kidneys Overcome Hyperacute Rejection in Human Trials
Medical researchers have successfully transplanted 10-gene edited pig kidneys into human recipients, overcoming the hist...
Read More →
BusinessIn Vivo CRISPR Base Editing: Verve-102 Offers 'One-and-Done' Permanent Cholesterol Reduction
Verve Therapeutics' in vivo CRISPR base editing program, VERVE-102, utilizes lipid nanoparticles to permanently disable ...
Read More →
BusinessBeyond Weight Loss: GLP-1 Agonists Demonstrate Profound Cardio-Renal Protection in Landmark Trials
Landmark trials like SELECT and FLOW have proven that GLP-1 agonists offer profound cardiovascular and renal protection,...
Read More →
BusinessmRNA-4157/V940: The Personalized Cancer Vaccine Rewriting the Rules of Oncology
mRNA-4157/V940, a personalized neoantigen therapy developed by Moderna and Merck, has demonstrated a 44% reduction in re...
Read More →
BusinessRevolutionary p-tau217 Blood Test Transforms Alzheimer’s Diagnosis and Accelerates Treatment Access
The p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accuracy and replacing c...
Read More →
BusinessPfizer and BioNTech Acquire Leading Biotech CDMO in $14B Pivot to Personalized mRNA Oncology Manufacturing
Pfizer and BioNTech have acquired Catalent’s biologics division for $14B to secure the critical manufacturing capacity...
Read More →
BusinessLockheed Martin and SpaceX Secure $35B Joint Contract for Cislunar Logistics and Orbital Manufacturing
Lockheed Martin and SpaceX have secured a $35B joint contract to build the Cislunar Logistics Network, merging defense e...
Read More →